CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
CBIO
30 hedge funds and large institutions have $174M invested in Crescent Biopharma, Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
-4
Holders Change %
-11.76%
% of All Funds
0.4%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
15
Increased
9
Reduced
5
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–